Royalty Report: Agriculture, Forestry and Fishing, Medical – Collection: 306254

$150.00

Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 11

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 11

Primary Industries

  • Agriculture
  • Forestry and Fishing
  • Medical
  • Device
  • Diagnostic
  • Disease
  • Test/Monitoring
  • Technical Know How
  • Food
  • Proteins

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 306254

License Grant
Licensor grants to Licensee an exclusive perpetual license to make, use, and practice the Patent for research, clinical, teaching, or other non- commercial purposes, but not for purposes of commercial development, use, manufacture, or distribution of any product other than as authorized with the written consent of Licensor.

Assignor hereby assigns to Assignee One Hundred Percent (100%) of its right, title and interest in the invention and IP and any reissues or extensions and for the entire terms of any patents, reissues or extensions that may issue from foreign applications, divisions, continuations in whole or part or substitute applications filed claiming the benefit of the IP. The right, title and interest conveyed in this Assignment is to be held and enjoyed by Assignee and Assignee’s successors as fully and exclusively as it would have been held and enjoyed by Assignor had this Assignment not been made.

License Property
Patent means Improved Fluorescent Resonance Energy Transfer Based Biosensor Proteins and their Methods of Use Thereof, U.S. Provisional Patent No. 62730424, filed on September 12, 2018.

Product means biosensors that use the patented technology described in the Patent.  Förster (or fluorescence) resonance energy transfer (FRET) is a process involving the radiation-less transfer of energy from a donor fluorophore to an acceptor fluorophore. FRET technology enables the quantitative analysis of molecular dynamics in biophysics and in molecular biology, such as the monitoring of protein-protein interactions, protein-DNA interactions, and protein conformational changes. FRET-based biosensors have been utilized to monitor cellular dynamics not only in heterogeneous cellular populations, but also at the single-cell level in real time.

Fluorescence Resonance Energy Transfer or “FRET” is a physical phenomenon that is increasingly being used in biomedical research and drug discovery. It is the distance-dependent transfer of energy from one fluorescent molecule (the donor) to another fluorescent molecule (the acceptor). The transfer of energy leads to a reduction in the donor’s fluorescence intensity and an increase in the acceptor’s emission intensity. Due to its sensitivity to distance, FRET has been used to investigate molecular interactions.

Licensor is a biotechnology company developing solutions to safely and sustainably increase natural crop yield and food security. Its mission is to develop breakthrough disruptive technologies that address the greatest agriculture, aquaculture, and environmental challenges facing the globe.

Field of Use
This agreement pertains to the agriculture industry for solutions to emerging diseases in plant and animal food production.

Licensee has a technology platform that measures the signature of infectious bacteria, enabling real-time and rapid response in medical, veterinary, pharmaceutical and aquatic applications.

IPSCIO Record ID: 306255

License Grant
Assignee re-grants the Assignor certain rights in and to the IP by a License Agreement and Royalty Agreement.

Licensee grants to Licensor an exclusive perpetual license of the IP

(a)
to make, use, and practice the IP for research, clinical, teaching, or other non-commercial purposes, but not for purposes of commercial development, use, manufacture, or distribution of any product in the field of the detection of microbial pathogens other than as authorized with the written consent of Licensee; and

(b)
to make, use, and practice the IP for research, clinical, teaching, or other non-commercial purposes as well as for any commercial purposes including but not limited to commercial development, use, manufacture, or distribution of any product in any field save and except for the field of the detection of microbial pathogens. Licensor covenants not to use the IP for all of the licensed IP rights granted to Licensor.

License Property
The Technology A portable instrument and associated software for measuring fluorescence resonance energy transfer (FRET) between pairs of fluorophores. The instrument, software, and methods developed can be used to measure FRET between any fluorophore pair and can make simultaneous measurements of multiple fluorophore pairs. The present instrument, software, and methods have been developed specifically for measurement of BAI-2 concentrations with single proteins containing FRET pairs and a BAI-2 binding domain. BAI-2 is a quorum-sensing molecule synthesized by bacterial pathogens. By measuring BAI-2, the instrument provides a method for detection of pathogenic bacteria and has applications in several industries including healthcare (the said invented portable instrument and associated software are, collectively, the Technology).

Fluorescence Resonance Energy Transfer or “FRET” is a physical phenomenon that is increasingly being used in biomedical research and drug discovery. It is the distance-dependent transfer of energy from one fluorescent molecule (the donor) to another fluorescent molecule (the acceptor). The transfer of energy leads to a reduction in the donor’s fluorescence intensity and an increase in the acceptor’s emission intensity. Due to its sensitivity to distance, FRET has been used to investigate molecular interactions.

Product means a device for detecting bacteria in bio-samples whereby such device is produced using any of the IP.

Field of Use
The instrument provides a method for detection of pathogenic bacteria and has applications in several industries including healthcare.

Pathogenic bacteria is a disease-causing bacteria. Pathogenic bacteria can contribute to many worldwide diseases, including tuberculosis, cholera, anthrax, leprosy, the bubonic plague, pneumonia, and food-borne illnesses. The most common fatal bacterial infectious diseases are respiratory infections

Licensee has a technology platform that measures the signature of infectious bacteria, enabling real-time and rapid response in medical, veterinary, pharmaceutical and aquatic applications.

IPSCIO Record ID: 382985

License Grant
In this related party agreement, the Inventor, an individual, of the acquired patents will be paid a royalty on sales of covered products.
License Property
Patent Family 1 is entitled “Harvesting, transmission, spectral modification and delivery of sunlight to shaded areas of plants,” and covers the Company’s core light harvesting technology. This family has a first filing date of 2013, is expected to expire in 2034, was originally filed by Licensor, and has since been acquired by Licensee. This patent family (including issued patent and pending applications) extends to a wide geography spanning major fruit producing regions across Europe, Israel, much of Latin America, China, and the United States. Representative issued US patent nos. 10,132,457 and 10,955,098 provide coverage of aspects of the Company’s foundational Skylight systems, and additional claim coverage is being pursued in a pending U.S. Continuation application.

10,132,457 – Harvesting, transmission, spectral modification and delivery of sunlight to shaded areas of plants
10,955,098 – Harvesting, transmission, spectral modification and delivery of sunlight to shaded areas of plants

Field of Use
This agreement relates to the agriculture industry and pertains to the harvesting, transmission, spectral modification and delivery of sunlight to shaded areas of plants.

The Opti-Filter technology provides a spectrally modified light environment, wind-breaking and improved microclimate that accelerates establishment and growth of newly planted tree crops, shortening time-to-production and maturity.
Opti-Filter products are designed to optimize land and water resources by utilizing sunlight in novel ways to accelerate growth in newly planted crops (Opti-Gro, Opti-Shield and ChromaGro products), and improve production in mature vineyards and orchards (Opti-Skylights and Opti-Panels products). Opti-Filter photo-selective technology turns sunlight into scattered, red-enriched light, maximizing the sun’s most productive rays and filtering out those that inhibit growth and production, which results in enhanced foliage activity, fruitfulness, shorter time to production, and substantial increases in marketable yield. These benefits are enhanced further by significant reductions in labor costs and other related expenses associated with conventional farming practices. Increasing outputs (yield, revenues) and lowering inputs (labor costs, resources) are age-old challenges for farmers.

IPSCIO Record ID: 217383

License Grant
The Licensee was party to a license agreement with the Canadian Licensor related to the Licensees transgenic fish program. Under the terms of this agreement, the Licensee was required to make an annual royalty payment or revenue-based royalty payments on revenue generated from products that utilize the technology which is based on a molecular modification causing rapid growth in salmon, covered under the license agreement
License Property
The fish program is based upon a single, specific molecular modification in fish that results in more rapid growth in early development. This enables shorter production cycles and increased efficiency of production.

The patent for the licensed technology, which had been issued in certain salmon producing countries, expired in August 2013.

Field of Use
The Licensee is involved in sustainable and environmentally responsible aquaculture.

IPSCIO Record ID: 229867

License Grant
The Company entered into in-license technology agreements with respect to the use and commercialization of three of their commercially available product lines, Regalia, Grandevo and Zequanox, and certain products under development.
License Property
Regalia is for controlling plant disease and increasing plant health, Grandevo for insect and mite control and Zequanox selectively controls invasive mussels that cause significant infrastructure and ecological damage across a broad range of in-pipe and open-water applications, including hydroelectric and thermoelectric power generation, industrial applications and recreation.
Field of Use
This agreement pertains to the agriculture industry.  A portfolio of products that address the growing global demand for effective, efficient and environmentally responsible products to control pests, increase crop yields and reduce crop stress.

IPSCIO Record ID: 230819

License Grant
Through performance of their respective obligations under this Agreement, Licensor and Licensee will use their respective commercially reasonable efforts jointly to conceive, design and develop commercially viable Gender Sorting Products. This collaboration will be conducted in three phases, the first of which has been completed.
License Property
Gender Sorting Services means and includes all gender classification and sorting services performed by Licensee and its customers, distributors, other sublicensees and permitted assignees utilizing the Gender Sorting Products.

Licensor is a company whose principal business is to research, design and commercialize cell-based biosensors and screens.

Field of Use
Field of Use means the in ovo and ex ovo gender classification of avian species.  Licensee is an agricultural biotechnology company focused on developing products that improve bird health, reduce bird production costs and provide other benefits to the poultry industry.

The Licensee believes that the economical and efficient in ovo determination of a bird's gender before it hatches will lead to an increase in the practice of raising birds separately by gender.

IPSCIO Record ID: 290208

License Grant
Licensor hereby grants Netherlands Licensee and its Affiliates a non-exclusive, worldwide, non-terminable license with the right to grant sublicenses, under the Licensor Patent Rights (other than the Licensor Antibody Patent Rights), for all uses in the Field, including, without limitation, to make, have made, use, sell, offer for sale, import and export Licensee Licensed Products in the Field. Such license shall not expire until the earlier of (i) the expiration of the last to expire Valid Claim of the Licensor Patent Rights other than the Licensor Antibody Patent Rights or (ii) termination of this Agreement of this Agreement.
License Property
Licensor Patent Rights shall mean (a) USSN 07/938,322 entitled 'Transgenic Animals Secreting Desired Proteins into Milk', including, without limitation, EP-973031124, and any foreign counterpart applications, together with any and all patents that have issued or in the case of applications heretofore filed, in the future issue therefrom or whose priority date is based thereon; and (b) all related divisionals,  continuations, national stage applications or patents filed under the Patent Cooperation Treaty of 1978, reissues or renewals, of the foregoing; and (c) the Licensor Antibody Patent Rights.

Licensor Antibody Patent Rights shall mean (a) U.S. Patent Nos. 5,827,690 and 5,849,992 both entitled 'Transgenic Production of Antibodies in Milk', and all U.S. patent applications and any foreign counterpart applications, and future issued patents including all patents that have issued or in the case of applications heretofore filed, in the future issue therefrom or whose priority date is based thereon; and all related divisionals, continuations, national stage applications or patents filed under the Patent Cooperation Treaty of 1978, reissues or renewals, of the foregoing pertaining to the production of antibodies in the milk of transgenic mammals.

Biopharmaceutical shall mean any medicinal drug, therapeutic, vaccine or any medically useful composition whose origin, synthesis, or manufacture involves the use of microorganisms, recombinant animals (including, without limitation, chimeric or transgenic animals), nuclear transfer, microinjection, or cell culture techniques.

HSA shall mean human serum albumin.

Field of Use
Field shall mean (a) the Cattle Field; (b) the Goat Field; (c) the production, use and/or sale of transgenic or chimeric mice, rabbits, pigs, and/or sheep (including their respective embryos, gametes and/or progeny) for the production of Biopharmaceuticals in the milk (including any fraction thereof) secreted from such transgenic or chimeric animals; and (d) the use in any transgenic or chimeric cattle, goats, mice, rabbits, pigs, and/or sheep of a nucleic acid construct useful in the production of a system that includes the use of a recombinant casein promoter sequence, which permits a female transgenic or chimeric animal to produce a desired Biopharmaceutical in the milk (or any fraction thereof) of such a transgenic or chimeric cattle, goats, mice, rabbits, pigs, and/or sheep
during lactation.

Goat Field shall mean the production, use and/or sale of transgenic or chimeric goats (including their respective embryos, gametes and/or progeny) for the production of Biopharmaceuticals in the milk (including any fraction thereof) secreted from such transgenic or chimeric goats.

Cattle Field shall mean the production, use and/or sale of transgenic or chimeric cattle (including their respective embryos, gametes and/or progeny) for the production of Biopharmaceuticals in the milk (including any fraction thereof) secreted from such transgenic or chimeric cattle, including, without limitation, the production of hSA.

IPSCIO Record ID: 367349

License Grant
Licensor hereby grants to German Licensee, an exclusive worldwide license for RICE under the Licensed Patents and the Licensed Know-How to use the Licensed Technology to make, have made, sell, have sold, offer for sale, have offered for sale, import, and use Products in the Territory and, to otherwise practice and use Licensed Technology.
License Property
Licensed Patents
US 6,538,182 – DNA encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5A, transgenic plants and a method for controlling senescence programmed and cell death in plants
US 6,878,860 – DNA encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5A, transgenic plants and a method for controlling senescence programmed and cell death in plants
US 7,033,833 – Polynucleotides encoding carnation senescense-induced EIF-5A

Rice Oryza sativa sp

eIF-5A is related to conferring useful traits, particularly increased seed Yield, in plants based on modulating the gene expression of eukaryotic translation initiation factor 5A.

Genes the eIF-5A gene described in the Licensed Patents filed by Licensor, and its Orthologs in the form of a chimeric gene to be introduced in Rice. Ortholog means any protein having 80% or more overall identity with the protein encoded by the selected base Gene.

Licensed Technology methods and means to modulate expression of eIF-5A.

Field of Use
Field of use is for increasing seed yield in plants for the agriculture industry.

Product any and all Hybrid RICE which contains the Gene, and which would infringe at least one Valid Claim of the Licensed Patents in the absence of a license under this Agreement.

Hybrid a Licensee’s best considered hybrid rice.

IPSCIO Record ID: 367288

License Grant
Licensor hereby grants to German Licensee, solely in Brassica, an exclusive license under the Licensed Patents and the Licensed Know-How to use the Licensed Technology to make, have made, sell, have sold, offer for sale, have offered for sale, import, and use Products in the Territory and, solely for Brassica, to otherwise practice and use Licensed Technology. The license granted includes the right for Licensee and its Affiliates to subcontract the implementation of activities covered by the license under responsibility of Licensee or its Affiliates, provided that the subcontractor shall implement such activities for the sole benefit and under the supervision of Licensee or its Affiliates.

From the Effective Date, Licensee is entitled to grant written sublicenses under the Licensed Patents and Licensed Know-How as licensed under this Agreement, solely in Brassica, to its Affiliates and any third party.

License Property
Licensor has developed certain technology related to conferring useful traits, particularly increased seed yield, in plants based on modulating the gene expression of eukaryotic translation initiation factor 5A (“eIF-5A”) and/or deoxyhypusine synthase (“DHS”).

Brassica cells, plants, seeds, part of plants of any species of the genus Brassica cultivated for oilseed production, including but not limited to Brassica napus, Brassica juncea, Brassica rapa, Brassica carinata.

Eukaryotic translation initiation factor 5A (eIF-5A) and/or deoxyhypusine synthase (DHS) relates to conferring useful traits, particularly increased seed yield, in plants based on modulating the gene expression.

Licensed Patents all Patents a) owned by Licensor and b) licensed-in, with the right to grant sublicenses, by Licensor, which relate to the Licensed Technology, including, without limitation, those Patents listed in ANNEX I.

US 6,538,182 – DNA encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5A, transgenic plants and a method for controlling senescence programmed and cell death in plants
US 7,033,833 – Polynucleotides encoding carnation senescense-induced EIF-5A
US 6,900,368 – Tomato antisense deoxyhypusine synthase molecule and method of inhibiting deoxyhypusine synthase expression in plants

Product any and all Brassica which contains at least one Gene Component, and which would infringe at least one Valid Claim of the Licensed Patents in the absence of a license under this Agreement.

Licensed Technology methods and means to modulate expression of eIF-5A and/or DHS (including all of their isoforms).

Field of Use
Field of use is for agriculture relating to increased seed yield in plants.

IPSCIO Record ID: 197618

License Grant
The French Licensor grants the Licensee, a subsidiary, an exclusive (except as otherwise provided) worldwide, perpetual license, with the right to sublicense under the Licensed IP to use, have used, make, have made, sell, have sold, offer for sale, export, import and otherwise exploit any and all Licensee Licensed Products within the Licensee Field of commercialization of agricultural and food products.
License Property
The Licensee's TALEN technology uses 'molecular scissors' to create desirable traits and does not add foreign DNA during the process.

Licensed TALEN Mark

Field of Use
The TALEN method produces plants regarded as non-GMO. That’s because unlike controversial GMO foods, there is no introduction of foreign DNA into the plant genome, such as is done to enhance the ability to crops to resist pesticides. Instead, the TALEN process is used only to strategically deactivate genes to achieve desired traits, such as to produce less fat in a soybean, and thus is seen as essentially no different from naturally occurring mutations.

The Licensee's aims to make genetically modified crops for consumers and farmers using technology developed at a French gene-editing

The Licensee is in the field of researching, developing and commercializing agricultural and food products, including, but not limited to traits, seeds, proteins, oils, carbohydrates, food, and food and animal feed ingredients, excluding any application in connection with animals and animal cells.

IPSCIO Record ID: 385344

License Grant
University grants Licensee an exclusive license and right in University’s rights under Patent Rights to make, have made, use, import, offer for sale, and sell the Licensed Products in the Territory, and to grant sublicenses of the same scope, to the end of the term of this Agreement. For the avoidance of doubt, this grant creates no obligation for the Parties, including Members, to collaborate on research or provide services to one another in the course of this Agreement. Should the Parties or Members and Licensee desire to enter into sponsored research, consulting, or service agreements related to Licensed Technology, such agreements will be separate from, and independent of, this Agreement and only entered into with the consent of all parties involved in such agreements.
License Property
University is the owner of a certain intellectual property related to shrimp production.

“LICENSED TECHNOLOGY” means SYSTEM’s proprietary technology relating to SYSTEM Disclosure of Invention Number 2832 entitled “High Density Shrimp Production Methods.”

“PATENT RIGHTS” means SYSTEM’s rights in United States patent number 8,336,498.

Field of Use
The proprietary Tidal Basin Technology aquaculture platform provides the ideal environment to produce shrimp and shrimp exoskeleton material.  The base of Licensee's Tidal Basin Technology is the super intense shallow water raceway technology.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.